United States Market Monthly Performance for April 2022

Monthly Gainers
923
Monthly Losers
4,020
Average Return
17.71%
Total Stocks
5,125
View Detailed Market Cap Breakdown
Market CapMonthly GainersMonthly LosersAverage ReturnTotal Stocks
Mega Cap 12 35 -8.71% 47
Large Cap 114 575 -7.47% 691
Mid Cap 141 768 -8.60% 922
Small Cap 73 395 -10.49% 476

Monthly Streak Leaders for April 2022

Stock Streak Streak Return
5 months โ†‘ 39.98%

Exxon Mobil shows promise with a 5-month winning streak (60.90 โ†’ 85.25), delivering 40.0% gains. Financial performance remains steady with 81.1B revenue yielding 8.0B profit (Qtr ending Mar 2025). The 9.9% margin suggests room for growth as operations scale.

3 months โ†‘ 18.25%

Eli Lilly and gains traction with a 3-month winning streak (247.05 โ†’ 292.13), delivering 18.2% gains. The financials tell a compelling story: 12.7B revenue generating 2.8B net profit (21.7% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

6 months โ†“ -72.37%

Netflix encounters challenges with a 6-month decline (689.06 โ†’ 190.36), down 72.4%. However, fundamentals remain robust: 10.5B revenue generating 2.9B profit (27.4% margin) as of Qtr ending Mar 2025 suggests this could be a temporary setback. Value hunters take note.

6 months โ†“ -30.62%

JPMorgan Chase sees continued selling pressure through a 6-month decline (172.04 โ†’ 119.36), down 30.6%. Weak margins on 45.3B revenue with only 14.6B profit (32.3% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

7 months โ†‘ 54.93%

McKesson maintains strong momentum with a 7-month winning streak (199.84 โ†’ 309.61), delivering 54.9% gains. With 90.8B revenue generating only 1.3B profit (1.4% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

7 months โ†‘ 36.22%

Corteva builds on success with a 7-month winning streak (42.35 โ†’ 57.69), delivering 36.2% gains. The financials tell a compelling story: 4.4B revenue generating 656.0M net profit (14.9% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

10 months โ†“ -74.15%

Pinterest experiences extended pressure with a 10-month decline (79.39 โ†’ 20.52), down 74.2%. Weak margins on 855.0M revenue with only 8.9M profit (1.0% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

10 months โ†“ -71.76%

Twilio faces persistent headwinds with a 10-month decline (396.00 โ†’ 111.82), down 71.8%. Weak margins on 1.2B revenue with only 20.0M profit (1.7% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before sentiment shifts.

7 months โ†‘ 61.40%

Adma Biologics maintains strong momentum with a 7-month winning streak (1.14 โ†’ 1.84), delivering 61.4% gains. The financials tell a compelling story: 114.8M revenue generating 26.9M net profit (23.4% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

6 months โ†‘ 44.76%

FMC shows consistent strength with a 6-month winning streak (91.56 โ†’ 132.54), delivering 44.8% gains. Despite 791.4M in revenue and - 15.6M loss (-2.0% margin) as of Qtr ending Mar 2025, the market sees potential beyond current profitability. This momentum suggests confidence in future execution.

10 months โ†“ -83.12%

Recursion struggles to find footing after a 10-month decline (36.72 โ†’ 6.20), down 83.1%. Financial struggles compound the decline: despite 14.8M revenue, - 202.5M losses persist (-1366.5% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted.

9 months โ†“ -44.25%

SolarWinds struggles to find footing after a 9-month decline (22.19 โ†’ 12.37), down 44.3%. However, fundamentals remain robust: 210.3M revenue generating 72.7M profit (34.6% margin) as of Qtr ending Dec 2024 suggests this could be a temporary setback. Value hunters take note.

5 months โ†‘ 223.93%

Alpha Metallurgical shows promise with a 5-month winning streak (47.77 โ†’ 154.74), delivering 223.9% gains. Despite 532.0M in revenue and - 33.9M loss (-6.4% margin) as of Qtr ending Mar 2025, the market sees potential beyond current profitability. This momentum suggests confidence in future execution.

5 months โ†‘ 97.55%

Helmerich & Payne starts to shine with a 5-month winning streak (23.30 โ†’ 46.03), delivering 97.6% gains. With 1.0B revenue generating only 3.0M profit (0.3% margin) in Qtr ending Mar 2025, the market prices in future margin expansion potential.

10 months โ†“ -89.97%

Ars Pharmaceuticals experiences extended pressure with a 10-month decline (31.01 โ†’ 3.11), down 90.0%. Financial struggles compound the decline: despite 8.0M revenue, - 33.9M losses persist (-425.7% margin) as of Qtr ending Mar 2025. Until profitability improves, caution remains warranted.

8 months โ†“ -90.38%

PLSE faces significant headwinds with 8 consecutive negative months, down 90.38%.

United States Market Monthly Gainers & Losers: April 2022

Top United States Stock Gainers (April 2022)

StockMonth OpenMonth CloseMonthly ChangeAvg Daily VolumeMonth Volume
$94.96 $100.00 6.45% 5.07M 111.50M
$17.92 $18.86 5.66% 61.22M 1.35B
$153.52 $160.55 5.07% 6.91M 151.98M
$62.33 $64.61 4.21% 14.53M 319.60M
$81.99 $85.25 3.22% 22.98M 505.63M
$51.34 $63.83 24.72% 7.35M 161.73M
$34.34 $39.75 15.52% 9.08M 199.67M
$30.37 $35.20 15.30% 6.92M 152.24M
$14.06 $14.18 14.63% 14.25M 313.57M
$25.33 $28.35 12.95% 963.54K 21.20M
$12.70 $13.60 37.93% 23 500
$33.27 $44.65 34.16% 356.17K 7.84M
$12.99 $17.03 30.50% 3.55M 78.02M
$2.60 $3.36 28.74% 266.65K 5.87M
$38.18 $47.55 26.36% 765.25K 16.84M
$0.04 $0.05 25.00% 3.34K 73.56K
$22.25 $27.31 23.02% 916.66K 20.17M
$8.82 $10.01 21.48% 1.73M 38.04M
$4.40 $5.13 17.66% 541.08K 11.90M
$133.46 $154.74 17.26% 537.04K 11.81M

Biggest United States Stock Losers (April 2022)

StockMonth OpenMonth CloseMonthly ChangeAvg Daily VolumeMonth Volume
$376.80 $190.36 -49.18% 18.33M 403.33M
$27.38 $18.55 -32.03% 505.20M 11.11B
$13.77 $10.40 -24.25% 29.35M 645.66M
$164.15 $124.28 -23.75% 66.59M 1.47B
$110.48 $85.52 -21.79% 78.14M 1.72B
$5.77 $6.22 -68.63% 9 200
$119.87 $57.96 -51.41% 7.47M 164.35M
$189.86 $112.71 -40.64% 3.94M 86.74M
$50.18 $30.24 -39.81% 13.73M 301.96M
$12.84 $7.87 -38.32% 4.40M 96.74M
$23.84 $9.09 -61.61% 1.48M 32.55M
$20.60 $10.14 -52.10% 7.05M 155.15M
$12.37 $6.49 -47.53% 1.38M 30.44M
$11.49 $6.26 -45.66% 278.11K 6.12M
$13.08 $7.07 -45.15% 403.38K 8.87M
$3.36 $3.12 -87.16% - -
$40.49 $10.59 -73.64% 165.75K 3.65M
$8.45 $3.79 -54.88% 798.21K 17.56M
$72.85 $33.76 -53.20% 8.29M 182.38M
$4.16 $2.12 -49.28% 929.80K 20.46M

Most Active United States Stocks During April 2022

StockMonth OpenMonth CloseMonthly ChangeAvg Daily VolumeMonthly Volume
$27.38 $18.55 -32.03% 505.20M 11.11B
$110.48 $85.52 -21.79% 78.14M 1.72B
$174.03 $157.65 -9.71% 76.72M 1.69B
$360.38 $290.25 -19.20% 69.13M 1.52B
$164.15 $124.28 -23.75% 66.59M 1.47B
$17.01 $14.16 -16.26% 60.98M 1.34B
$22.41 $16.70 -20.67% 58.32M 1.28B
$9.47 $6.12 -35.24% 43.71M 961.67M
$18.30 $18.77 2.85% 35.00M 770.06M
$68.76 $42.68 -36.86% 31.62M 695.54M
$36.20 $28.46 -20.92% 29.69M 653.18M
$20.35 $17.30 -14.44% 29.20M 642.46M
$25.39 $18.08 -28.82% 19.61M 431.45M
$28.79 $21.02 -26.53% 18.41M 404.94M
$32.46 $25.49 -20.86% 17.94M 394.61M
$4.71 $4.25 -7.41% 15.50M 340.96M
$15.02 $11.01 -26.35% 13.58M 298.71M
$6.59 $3.79 -42.31% 12.00M 264.06M
$1.63 $1.31 -18.12% 10.92M 240.18M
$24.75 $22.64 -7.70% 8.91M 195.91M

United States Sector Performance During April 2022

Healthcare

87.89%
1089 stocks
Top Performers by Market Cap:
Mega Cap: LLY +2.01%
Large Cap: RPRX +9.29%
Small Cap: IMCR +9.06%

Basic Materials

11.83%
246 stocks
Top Performers by Market Cap:
Mega Cap: LIN -2.34%
Large Cap: SHW +10.15%
Small Cap: AMR +17.26%

Utilities

4.99%
90 stocks
Top Performers by Market Cap:
Large Cap: VST +7.61%
Mid Cap: SWX +12.54%
Small Cap: HE -2.84%

Industrials

3.90%
587 stocks
Top Performers by Market Cap:
Mega Cap: GE -18.52%
Large Cap: UAL +8.93%
Small Cap: JBI +5.11%

Communication Services

3.24%
230 stocks
Top Performers by Market Cap:
Mega Cap: T +5.66%
Large Cap: RCI -4.04%
Mid Cap: RUM +5.14%
Small Cap: GRPN +1.46%

Financial Services

3.05%
852 stocks
Top Performers by Market Cap:
Mega Cap: MA +1.68%
Large Cap: SYF +5.75%
Small Cap: RENEW +0.00%

Energy

-0.59%
190 stocks
Top Performers by Market Cap:
Mega Cap: XOM +3.22%
Large Cap: EQT +15.52%
Mid Cap: CRK +30.50%
Small Cap: HPK +23.02%

Consumer Defensive

-3.96%
208 stocks
Top Performers by Market Cap:
Mega Cap: PM +6.45%
Large Cap: PPC +12.95%
Small Cap: UTI +17.06%

Consumer Cyclical

-4.90%
523 stocks
Top Performers by Market Cap:
Mega Cap: MCD +0.76%
Large Cap: PAG +11.84%
Small Cap: PLYA +9.13%

Real Estate

-6.42%
254 stocks
Top Performers by Market Cap:
Large Cap: BEKE +14.63%
Mid Cap: RYN +5.06%
Small Cap: DRH +5.15%

Technology

-10.89%
709 stocks
Top Performers by Market Cap:
Mega Cap: IBM +1.68%
Large Cap: SAIL +24.72%
Small Cap: BBAI +21.48%

Data is updated regularly. Monthly performance is calculated based on closing prices.